| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 13.717 | 14.557 | 13.128 | 9.853 | - |
| Total Income - EUR | - | - | - | - | - | 13.717 | 14.557 | 13.128 | 9.853 | - |
| Total Expenses - EUR | - | - | - | - | - | 8.255 | 5.585 | 5.922 | 7.448 | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.462 | 8.973 | 7.206 | 2.405 | - |
| Net Profit/Loss - EUR | - | - | - | - | - | 5.262 | 8.608 | 6.871 | 2.021 | - |
| Employees | - | - | - | - | - | 1 | 1 | 0 | 0 | - |
Check the financial reports for the company - Caltic Taseprim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 5.214 | 5.099 | 5.115 | 5.099 | - |
| Current Assets | - | - | - | - | - | 2.126 | 8.901 | 10.996 | 9.667 | - |
| Inventories | - | - | - | - | - | 413 | 404 | 406 | 625 | - |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 6.236 | - |
| Cash | - | - | - | - | - | 1.713 | 8.497 | 10.590 | 2.807 | - |
| Shareholders Funds | - | - | - | - | - | 6.993 | 13.021 | 15.877 | 14.564 | - |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | - | - | 347 | 979 | 234 | 202 | - |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4933 - 4933" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Caltic Taseprim S.r.l.